BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 10915216)

  • 1. Estrogen biosynthesis in endometriosis: molecular basis and clinical relevance.
    Bulun SE; Zeitoun KM; Takayama K; Sasano H
    J Mol Endocrinol; 2000 Aug; 25(1):35-42. PubMed ID: 10915216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of aromatase in endometrial disease.
    Bulun SE; Yang S; Fang Z; Gurates B; Tamura M; Zhou J; Sebastian S
    J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):19-25. PubMed ID: 11850203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of excessive estrogen formation in endometriosis.
    Bulun SE; Gurates B; Fang Z; Tamura M; Sebastian S; Zhou J; Amin S; Yang S
    J Reprod Immunol; 2002; 55(1-2):21-33. PubMed ID: 12062819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen production and metabolism in endometriosis.
    Bulun SE; Yang S; Fang Z; Gurates B; Tamura M; Sebastian S
    Ann N Y Acad Sci; 2002 Mar; 955():75-85; discussion 86-8, 396-406. PubMed ID: 11949967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aromatase as a therapeutic target in endometriosis.
    Bulun SE; Zeitoun KM; Takayama K; Simpson E; Sasano H
    Trends Endocrinol Metab; 2000; 11(1):22-7. PubMed ID: 10652502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis.
    Bulun SE; Zeitoun K; Takayama K; Noble L; Michael D; Simpson E; Johns A; Putman M; Sasano H
    Endocr Relat Cancer; 1999 Jun; 6(2):293-301. PubMed ID: 10731122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target.
    Zeitoun KM; Bulun SE
    Fertil Steril; 1999 Dec; 72(6):961-9. PubMed ID: 10593363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aromatase inhibitors--theoretical concept and present experiences in the treatment of endometriosis].
    Ebert AD; Bartley J; David M; Schweppe KW
    Zentralbl Gynakol; 2003; 125(7-8):247-51. PubMed ID: 14505258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis for treating endometriosis with aromatase inhibitors.
    Bulun SE; Zeitoun KM; Takayama K; Sasano H
    Hum Reprod Update; 2000; 6(5):413-8. PubMed ID: 11045871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aromatase and other steroidogenic genes in endometriosis: translational aspects.
    Attar E; Bulun SE
    Hum Reprod Update; 2006; 12(1):49-56. PubMed ID: 16123052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen production and action.
    Nelson LR; Bulun SE
    J Am Acad Dermatol; 2001 Sep; 45(3 Suppl):S116-24. PubMed ID: 11511861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endometriosis and aromatase inhibitor].
    Takayama K; Bulun SE
    Nihon Rinsho; 2001 Jan; 59 Suppl 1():157-60. PubMed ID: 11235156
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of severe postmenopausal endometriosis with an aromatase inhibitor.
    Takayama K; Zeitoun K; Gunby RT; Sasano H; Carr BR; Bulun SE
    Fertil Steril; 1998 Apr; 69(4):709-13. PubMed ID: 9548162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aromatase and endometriosis.
    Bulun SE; Fang Z; Imir G; Gurates B; Tamura M; Yilmaz B; Langoi D; Amin S; Yang S; Deb S
    Semin Reprod Med; 2004 Feb; 22(1):45-50. PubMed ID: 15083380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatase inhibitors and cyclooxygenase-2 (COX-2) inhibitors in endometriosis: new questions--old answers?
    Ebert AD; Bartley J; David M
    Eur J Obstet Gynecol Reprod Biol; 2005 Oct; 122(2):144-50. PubMed ID: 16157442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen metabolizing enzymes in endometrium and endometriosis.
    Dassen H; Punyadeera C; Kamps R; Delvoux B; Van Langendonckt A; Donnez J; Husen B; Thole H; Dunselman G; Groothuis P
    Hum Reprod; 2007 Dec; 22(12):3148-58. PubMed ID: 17921479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aromatase in aging women.
    Bulun SE; Zeitoun K; Sasano H; Simpson ER
    Semin Reprod Endocrinol; 1999; 17(4):349-58. PubMed ID: 10851574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial Intracrinology--generation of an estrogen-dominated microenvironment in the secretory phase of women.
    Gibson DA; McInnes KJ; Critchley HO; Saunders PT
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1802-6. PubMed ID: 24014622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging use of aromatase inhibitors for endometriosis treatment.
    Nothnick WB
    Reprod Biol Endocrinol; 2011 Jun; 9():87. PubMed ID: 21693036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators.
    Geisler J
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):245-53. PubMed ID: 14623518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.